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In the present study, micronucleus with cytokinesis blocking and comet assayswere used to
evaluate the genotoxic potential of Bothrops jararacussu, Bothrops atrox, Bothrops moojeni,
Bothrops alternatus (Rhinocerophis alternatus) and Bothrops brazili snake venoms, and also of
some isolated toxins (MjTX-I, BthTX-I and II myotoxins, BjussuMP-II metalloprotease, and
BatxLAAO L-amino acid oxidase) on human lymphocytes. Signiﬁcant DNA damages were
observed, indicating genotoxic potential after exposure of the lymphocytes to the toxins
BthTX-I, II and BatxLAAO compared to untreated and Cisplatin-treated controls, which were
able to induce greater formation of micronuclei. B. brazili, B. jararacussu and B. atrox crude
venoms also presented genotoxic potential, and the latter two induced DNA breakage 5
times more often than in normal environmental conditions (control without treatment). B.
jararacussu venom and its isolated toxins, as well as an LAAO from B. atrox, were able to
cause lymphocyte DNA breakage in the comet test with more than 85% damage levels. The
DNA damage evaluation allows awidening of the toxic-pharmacological characterization of
snake venoms and their toxins and also contributes to the understanding of themechanisms
of action of these molecules in several human pathologies.
 2013 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
Bothrops snake venoms are mainly composed of en-
zymes such as phospholipases A2 (PLA2s), metalloproteases; fax: þ55 69 3219
moléculas Aplicadas
, Brazil. Fax: þ55 69
arcussi), andreims@
lsevier OA license.(SVMPs), and L-amino acid oxidases (LAAOs), that can
induce a wide range of toxic effects, such as myotoxicity,
hemorrhage, blood coagulation, neurotoxicity, cytotoxicity,
edema, cellular apoptosis, genotoxicity, as well as others of
medical interest, such as antimicrobial, antiparasitic, anti-
fungal and antiviral activities (Iwanaga and Suzuki, 1979;
Kang et al., 2011; Vonk et al., 2011; Marcussi et al., 2011;
Soares, 2012).
PLA2s from Bothrops venoms are the main components
responsible for cellular damage through the hydrolysis of
membrane phospholipids. Those PLA2s known as myo-
toxins belong to the IIA group of PLA2s and may be
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example, Bothrops jararacussu BthTX-II), with low to
moderate enzymatic activity, and (ii) Lys49 myotoxins (as
B. jararacussu BthTX-I), which do not show any hydrolytic
activity on synthetic substrates (Soares et al., 2004;
Lomonte and Gutiérrez, 2011; Lomonte and Rangel,
2012).
BjussuMP-II is a P–I class metalloprotease isolated from
B. jararacussu venomwithmolecular mass of 24 kDa, which
showed ﬁbrinogenolytic and caseinolytic activities, with-
out presenting hemorrhagic or myotoxic effects (Marcussi
et al., 2007). An LAAO from Bothrops atrox, named Batx-
LAAO, is a single-chained glycoprotein with a molecular
mass of 67 kDa, pI 4.4 and 12% sugar content. It presents
moderate edematogenic activity and does not induce
hemorrhage. Moreover, it presents cytotoxic activity on
different tumor cells, but not on normal cells (mononuclear
cells from peripheral blood) (Alves et al., 2008).
Molecules isolated from venoms show a signiﬁcant
medical-scientiﬁc relevance due to their action on cells,
and could be used in structural studies in order to improve
the understanding of several cell processes and mecha-
nisms. Thesemolecules can also be used as models in to the
development of new therapeutic agents that could be used
in new therapies for snakebite accidents and pathologies,
such as cancer, thrombosis and hypertension (Koh et al.,
2006; Lomonte et al., 2010; King, 2011; Koh and Kini,
2012; Soares, 2012).
Considering several papers that describe the therapeu-
tic potential of animal venom toxins for various diseases,
the evaluation of their toxicity against human cells is
necessary to gauge the difference between non effective,
therapeutic or toxic doses for these molecules in order to
adjust administration protocols.
Genotoxicity evaluation of venoms and their isolated
toxins is a powerful tool for the identiﬁcation of potential
therapeutic agents for the treatment of some cancer types,
and shows signiﬁcant information for the understanding of
the mechanisms of action of these toxins. The present work
aims to evaluate the genotoxic potential of venoms from B.
jararacussu, Bothrops alternatus (Rhinocerophis alternatus),
B. atrox, Bothrops brazili and Bothrops moojeni together with
some isolated toxins (BthTX-I, BthTX-II, MjTX-I, BjussuMP-
II and BatxLAAO) by micronucleus and comet assays using
human lymphocytes.
2. Material and methods
2.1. Chemical agents
Doxorubicin (DXR, Rubidox, chemical abstract service
register number 25316-40-9) was kindly provided by Lab-
oratório Químico Farmacêutico Bergamo Ltda (São Paulo,
Brazil). DXR was diluted with distilled water according to
manufacturer recommendations. Cisplatin (PLATINIL) was
kindly provided by Quiral Química do Brasil S.A. RPMI 1640
medium, penicillin/streptomycin, phytohemagglutinin and
fetal bovine serum were purchased from Cultlab. Cyto-
chalasin B and ethidium bromide were purchased from
Sigma Aldrich. All other reagents used were of the highest
purity degree.2.2. Toxins and venoms
Dried crude Bothrops venoms were obtained from Bio-
agents Serpentarium, Batatais-SP, Brazil. Toxins MjTX-I,
BthTX-I and II were isolated from B. moojeni and B. jarar-
acussu snake venom, respectively, as previously described
by Andrião-Escarso et al. (2000); BjussuMP-II was isolated
from B. jararacussu snake venom according to Marcussi
et al. (2007); BatxLAAO was isolated from B. atrox snake
venom as previously described by Alves et al. (2008).
2.3. Micronucleus assay
2.3.1. Cell preparation and materials
Human blood was obtained from 6 healthy volunteers
between 18 and 30 years old, women or men, after
obtaining their formal consent. Volunteers have not made
use of any medication in a minimum period of one month
before the blood collection. Brieﬂy, venous blood was col-
lected in heparinized tubes and distributed in fractions of
500 mL per ﬂask for cultivation. Peripheral blood mono-
nuclear cells (PBMCs) were cultivated in total blood RPMI
1640 medium (5 mL) supplemented with 10% fetal bovine
serum (FBS, Gibco BRL), 100 U/mL penicillin and strepto-
mycin and 1% phytohemagglutinin (Gibco BRL) in 5% CO2 at
37 C. Experiments were approved by the Research Ethics
Committee of FCFRP-USP (n 102).
2.3.2. Cell viability
In order to determine the concentrations of venoms or
toxins which would allow the evaluation of the DNA
damage without affecting the cell cycles or inducing cell
death, cellular viability tests were performed using a con-
centration response curve before carrying out the micro-
nucleus and comet tests. The toxicity of samples on human
lymphocytes, using ﬁcoll, was assayed using the Trypan
blue exclusion method after incubation of cells with sam-
ples of B. jararacussu snake venom or BthTX-I at the con-
centrations of 5, 15 and 30 mg/mL for 24 h. Viable cells were
determined based on the ability of cells to exclude the dye.
2.3.3. Cytokinesis-block micronucleus (CBMN) test
This test allows the observation of human lymphocytes
after one nuclear-division phase in the presence of treat-
ments. Samples were tested at three different concentra-
tions (5, 15 and 30 mg/mL). Three cell culture ﬂasks were
used for each concentration/experiment totalizing 6 dif-
ferent volunteers. The mutagenic potential on human cell
cultures was analyzed for B. jararacussu, B. alternatus, B.
atrox, B. moojeni and B. brazili crude venoms and isolated
toxins (BthTX-I, BthTX-II, BjussuMP-II and BatxLAAO). The
samples were added 24 h after the initiation of the cultures.
After 44 h, cytochalasin-B (4 mg/mL, Sigma) was added to
the cultures. The CBMN test preparations were performed
according to Fenech and Morley (1985a,b). The analyses
were carried out after 72 h. Scores were taken according to
the criteria of Fenech (2000). All slides were coded and
scored blindly. Three slides were made for each ﬂask/
treatment/experiment, and 1000 binuclear cells were
counted considering the presence or absence of micro-
nuclei, this way making it possible to determine the
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values obtained for the controls that contained only cells
and culture media, in which the micronuclei formation
mean was of approximately 1.0, mean values higher than 2
micronuclei/1000 binuclear cells (MN/1000 BN cells) were
considered signiﬁcant for the assayed samples. The anti-
neoplastic drug, Cisplatin (PLATINIL, Quiral Química do
Brasil S.A.) (6 mg/mL) was used as positive control.
2.3.4. Cell proliferation index
The cytokinesis-block proliferation index (CBPI) was
calculated by counting 500 cells, considering the number of
nuclei (mono, bi, tri or tetranucleated). The CBPI deﬁnes
whether the cultures are multiplying normally after the
addition of samples. The following formula was used ac-
cording to Kirsch-Volders (1997): CBPI ¼ [1 (mono) þ
2 (bi) þ 3 (tri þ tetra)] / 500.
2.4. Comet assay
2.4.1. Nucleoid preparation and comet assay
This test was performed according to the methodology
described by Singh et al. (1988). The lymphocytes were
cultured in total blood obtained from 6 healthy volunteers
and each one corresponded to one experiment. The con-
centration and incubation times were performed according
to Marcussi et al. (2011). Three cell culture ﬂasks were used
for each treatment/experiment, and the culture period was
of 7 h at 37 C. The cells were incubated with different
treatments for 4 h at 37 C, andwere thenutilized toprepare
the slides before the ﬁrst cellular division. A cellular sus-
pension containing approximately 105 cells/mL was used to
obtain 5–8million cells per slide. Three slidesweremade for
each ﬂask of each treatment/experiment, although only 100
nucleoids were evaluated per ﬂask/treatment/experiment-
volunteer, totalizing 300 nucleoids/treatment/volunteer.
Approximately 60 mL of each cell culture were trans-
ferred tomicrotubes containing 300 mL of LMP (lowmelting
point) agarose, for the slides preparation in triplicate. The
mixture was homogenized and dropped on the slides
(100 mL/slide) with NMP (normal melting point) agarose
and covered with the coverslips. The cells were submitted
to 4 C for 10 min, and after that, the coverslips were
removed and the slides immersed in lyses solution (con-
taining 0.25 M NaCl, 100 mM EDTA, 10 mM Trizma base, pH
10 adjusted with 10 M NaOH, 5% DMSO and 1% Triton X-
100), remaining there for 2 h, being this procedure
responsible for the achievement of the nucleoid. Doxor-
ubicin (Bergamo Ltda) (2 mg/mL) was used as a positive
control. All the procedures described above and the elec-
trophoresis were carried out in the dark.
2.4.2. Electrophoresis
Before the electrophoretic run, the slides were kept in
electrophoresis solution (300 mM sodium hydroxide and
1 mM EDTA, pH 13) for 20 min at 4 C. The electrophoretic
runwas programmed at 25 V and 300mA, and the run time
was ﬁxed as 25 min. After the run, the slides were
immersed in neutralization solution (0.4 M Tris–HCl, pH
7.4) for 10 min, dried at room temperature and ﬁxed with
100% ethanol for 3 min.2.4.3. Staining and analysis
The coloration was performed with ethidium bromide
solution at 20 mg/mL. To that end, 100 mL of this solution
was placed over each slide, protected from light, covered
with a coverslip and immediately analyzed by ﬂuorescence
microscopy at 400X. Comet standards were analyzed by
visual scores according to Collins et al. (1993), with mini-
mal modiﬁcations as previously described (Marcussi et al.,
2011). The cells analyzed were classiﬁed by DNA injury
extent in 5 classes: class 0, without damage (damage <5%);
class 1, low level of damage (5–20%); class 2, medium level
of damage (20–40%); class 3, high level of damage (40–95%)
and class 4, totally damaged (damage> 95%). In order to
perform comparative analysis, data were calculated with
arbitrary units as described by Collins (2004).
2.5. Statistical analysis
Data are presented as means with standard deviations
(mean  S.D.). A p value of less than 0.05 was deemed to be
statistically signiﬁcant (Kruskal–Wallis).
3. Results
Initially, cell viability tests were performed using
a concentration response curve, before carrying out the
micronucleus and comet tests, in order to determine the
quantities of venoms or toxins which allowed the evalua-
tion of the DNA damage without affecting the cell cycles or
inducing cell death. The effective doses chosen were 5, 15
and 30 mg/mL. As positive control the mutagenic and
antineoplastic drug Cisplatin was used (6 mg/mL).
The micronucleus test indicated that BthTX-I and
BthTX-II from B. jararacussu and BatxLAAO from B. atrox
were potentially genotoxic as there were more than 2 MN/
1000 BN cells for a mean of 6 experiments with 30 mg/mL
(7.6, 8.7 and 6.6 respectively) (Table 1), suggesting a po-
tential genotoxic effect. Concerning the crude venoms, only
B. jararacussu and B. atrox showed to be potentially geno-
toxic, yielding (at 30 mg/mL) an average of 6 and 7.3 MN/
1000 BN cells in 6 experiments performed with lympho-
cytes isolated from the blood of the 6 volunteers (Table 2).
These results conﬁrm the signiﬁcance of myotoxins and
LAAOs in the composition of B. jararacussu and B. atrox
venom. The mean values obtained for the cytokinesis-
blocking proliferating index (CBPI) show that the treated
cultures were similar to those of the untreated cultures
(negative controls), demonstrating that toxin and venom
concentrations used were not cytotoxic to cells and there-
fore do not interfere with their development and division
(Tables 1 and 2), as observed for Crotalus durissus terriﬁcus
snake venom and its isolated toxins at concentrations of 1,
3 and 6 mg/mL (Marcussi et al., 2011). Data showed no
signiﬁcant differences between male and female regarding
the induction of micronuclei, allowing the pooling of re-
sults in Tables 1 and 2.
Although it is not possible to determine precisely
whether there was an apoptotic or necrotic effect of the
toxins on the lymphocytes, signiﬁcant morphologic differ-
ences between cells after the treatments were observed. In
the slide related to BthTX-I and BthTX-II (15 and 30 mg/mL),
Table 1
Distribution of micronuclei and cytokinesis-blocking proliferating index (CBPI) in cells treated with different toxins from Bothrops venoms or with the
antitumor agent Cisplatin (6 mg/mL).
Treatments (mg/mL) % Cell/500 cells MN/1000 BN
cells, mean  S.D.
CBPI  S.D.
Mono Bi Tri Multi
Cisplatin 6 38.7 33.8 15.3 12.2 13.8  0.15 1.89  0.01
Negative control – 35.6 34.6 16.7 13.1 1.0  0.05 1.94  0.06
BthTX-I 5 39.3 36.1 15.8 8.8 3.8  0.03a,b 1.85  0.03
15 32.8 38.6 15.2 13.4 5.4  0.07a,b 1.96  0.04
30 36.8 36.6 13.8 12.8 7.6  0.09a 1.89  0.02
BthTX-II 5 34.1 37.9 15.2 12.8 3.9  0.08a,b 1.94  0.02
15 36.8 36.5 15.9 10.8 6.5  0.08a,b 1.90  0.05
30 38.5 37.9 13.6 10.0 8.7  0.2a 1.85  0.03
BjussuMP-II 5 34.6 39.7 13.2 12.5 1.0  0.02b 1.91  0.02
15 34.5 39.7 13.0 12.8 1.1  0.02b 1.91  0.04
30 33.9 39.6 13.8 12.7 1.5  0.06b 1.92  0.08
BatxLAAO 5 39.9 14.7 11.7 33.7 1.6  0.03a,b 1.93  0.03
15 39.0 16.5 10.5 33.9 4.3  0.18a,b 1.93  0.05
30 43.1 14.1 10.5 32.2 6.6  0.12a,b 1.92  0.06
BN: binucleated cells; MN: micronuclei; CBPI: cytokinesis-blocking proliferating index. 1000 binuclear cells were analyzed per volunteer for each treatment,
with six volunteers. Data are represented as means  S.D. The values of CBPI were not statistically different compared to the control (p < 0.05).
a Signiﬁcantly different from the negative control (p < 0.05).
b Signiﬁcantly different from the positive control, Cisplatin (p < 0.05).
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possibly presenting necrotic nuclei (data not shown).
The myotoxin isolated from B. moojeni (MjTX-I) did not
show high rates of DNA damage when assayed by the
comet test, however, its genotoxic potential was revealed
when these rates were compared with the results obtained
for the negative control. The damages observed in the DNA
of lymphocytes were most pronounced after treatment
with the crude venoms from B. jararacussu and B. atrox and
the toxins BthTX-I, II and BatxLAAO. The standardization of
the comet assay for the evaluation of snake venom toxins
was performed according to Marcussi et al. (2011). The
concentration chosen (7.5 mg/mL) did not induce cell death
but resulted in DNA damage. In this test, the isolated toxins
showed similar results to the positive control. However,Table 2
Distribution of micronuclei and cytokinesis-blocking proliferating index (CBPI) in
Cisplatin (6 mg/mL).
Treatments (mg/mL) % Cell/500 cells
Mono Bi Tr
Cisplatin 6 45.4 42.2 9
Negative control – 41.5 40.3 10
B. jararacussu 5 37.6 35.8 13
15 39.9 40.4 14
30 41.4 40.2 12
B. alternatus 5 40.6 37.2 13
15 39.0 36.2 14
30 41.8 33.4 13
B. moojeni 5 46.4 36.5 10
15 45.1 38.4 11
30 40.1 40.7 8
B. brazili 5 43.1 41.2 7
15 41.4 38.6 8
30 38.9 39.5 12
B. atrox 5 38.5 44.6 10
15 42.3 38.1 11
30 40.5 43.8 9
a Signiﬁcantly different from the negative control (p < 0.05).
b Signiﬁcantly different from the positive control Cisplatin (p < 0.05).BjussuMP-II induced more genotoxicity than the control
drug, doxorubicin, at the concentration used. In contrast,
BatxLAAO induced lower damage than that observed for
the positive control, but greater damage than that obtained
for the culture without treatment (negative control). The
values of arbitrary units calculated according to Collins
(2004) clearly show signiﬁcant differences between con-
trols and treatments.
Crude venoms from B. jararacussu and B. brazili showed
similar genotoxicity to that of isolated toxins, but B. alter-
natus, B. atrox and B. moojeni crude venoms showed no
statistical differences in relation to the negative control
(Table 3). The obtained results suggest that venoms from
different species belonging to the same genus present dif-
ferent genotoxic properties.cells treated with different Bothrops venoms or with the antitumor agent
MN/1000 BN
cells, mean  S.D.
CBPI  S.D.
i Multi
.2 3.2 14.1  0.03 1.67  0.02
.6 7.6 1.2  0.05 1.77  0.01
.8 12.8 1.7  0.02b 1.89  0.03
.1 5.6 2.8  0.01a,b 1.80  0.02
.8 5.6 6.0  0.01a,b 1.77  0.07
.2 9.0 1.0  0.05b 1.82  0.03
.0 10.8 1.5  0.07b 1.86  0.05
.5 11.3 2.0  0.03a,b 1.83  0.06
.2 6.9 1.1  0.02b 1.71  0.04
.3 5.2 2.3  0.01a,b 1.71  0.02
.5 10.7 2.7  0.02a,b 1.79  0.01
.4 8.3 2.3  0.04a,b 1.73  0.03
.6 11.4 3.7  0.02a,b 1.79  0.04
.5 9.1 4.1  0.03a,b 1.83  0.04
.6 6.3 2.5  0.05a,b 1.78  0.07
.4 8.2 4.2  0.08a,b 1.77  0.05
.8 5.9 7.3  0.04a,b 1.75  0.08
Table 3
Frequencies of cells with comet and distribution of comet classes after treatment with Bothrops snake venoms, isolated toxins and the antitumor agent
doxorubicin (DXR, 2 mg/mL).
Treatments (7.5 mg/mL) Cells with
comet (%)
Arbitrary
units (0–400)
Comet classes (%)
0 1 2 3 4
Negative control 27.75 28.75 72.25 26.75 1 0 0
Positive control (DXR) 69.25 121.5 30.75 37 18 8.5 5.75
Toxins
BthTX-I 70.25a 108.25 29.75 45.5 14.75 6.75 3.25
BthTX-II 67.25a 97.75 32.75 49 9.25 5.75 3.25
MjTX-I 32.5b 44 67.5 23.5 6.5 2.5 0
BjussuMP-II 85.25a,b 153.75 14.75 37.5 31.5 11.75 4.5
BatxLAAO 57.5a,b 80.25 42.5 45.25 5.5 3 3.75
Venoms
B. jararacussu 67a 110 33 40 15 8 4
B. alternatus 36b 48 64 30 1 4 1
B. atrox 38b 38 62 38 0 0 0
B. moojeni 33b 36 67 30 3 0 0
B. brazili 56a 66 44 48 6 2 0
Data represent themean of each treatment S.D. for 6 individual experiments, one for each volunteer. Three ﬂasks were prepared for each treatment and for
each volunteer’s blood, with cells remaining in culture for 7 h. 100 nucleoids were observed by ﬂask, with three ﬂasks per treatment/volunteer resulting in
a total of 300 nucleoids.
Arbitrary units (0–400) calculated according to Collins (2004).
a Signiﬁcantly different from the negative control (p < 0.05).
b Signiﬁcantly different from the positive control DXR (p < 0.05).
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In a previous paper, the micronucleus method was
applied in human lymphocytes in order to evaluate the
genotoxic potential of C. durissus terriﬁcus snake venom
and its isolated toxins and the results showed signiﬁcant
DNA damage production (Marcussi et al., 2011). The pres-
ence of micronuclei indicated breakage and/or aneuploid
induction in DNA produced by the venom and toxins tested,
showing that these breakages were not likely to be cor-
rected during the process of checking and cell repair
resulting in permanent damage that could produce changes
in cell morphology or physiology, and may also be trans-
mitted hereditarily to future generations (Fenech and
Morley, 1985a,b; Fenech, 2007, 2008).
The chromosome damage observed in genotoxic assays
performed with animal venoms showed that these toxins
may possibly be used in the development of new thera-
peutic strategies for cancer control. There are some inter-
esting examples with venoms from scorpions, bees and
snakes (Zargan et al., 2011; Lee et al., 2007; Varanda et al.,
1999; Wang et al., 2000; Wang and Groopman, 1999; Lerda
et al., 2005; Brugger et al., 2006; Dönmez-Altuntas et al.,
2007).
The obtained results suggest that different toxins could
induce breakages in DNA by different ways, which is cor-
roborated by the results obtained with BthTX-I, BthTX-II
and BatxLAAO, which resulted in permanent breakages
likely to be observed in the micronucleus assay. Conversely,
the high rate of DNA breakage induced by BjussuMP-II is
not maintained after the action of cell repair system, as
observed in the micronucleus assay. Interesting, BthTX-I is
an enzymatically inactive PLA2-like enzyme and showed
similar mutagenic effect to BthTX-II, which is catalytically
active, suggesting that the genotoxicity is not related to the
catalytic activity.
The mechanisms of action of snake venom genotoxicity
are not yet elucidated. The production of free radicalsinduced by some toxins is a valuable hypothesis that should
be considered, since they participate in inﬂammatory pro-
cesses and the mediators are intimately related to the oxi-
dative stress. However, the apoptosis induction cannot be
discarded considering the high number of published works
describing this effect for different classes of toxins such as
LAAOs, metalloproteases and PLA2s (Iwanaga and Suzuki,
1979; Kang et al., 2011). Corroborating this hypothesis, the
induction of oxidative stress has been described for some
snake venoms and isolated toxins (Zhang and Cui, 2007;
Yamasaki et al., 2008). This effect can also be associatedwith
the DNA damage induced by venom toxins, through the
formation of free radicals that could inducegenotoxicityand,
in high levels, even mutagenicity or cellular apoptosis. The
induction of micronuclei and DNA damage of lymphocytes
observed after cell exposure to different concentrations of an
LAAO from B. atrox showed in the present work are an
indication that substantiates the hypothesis cited above.
Future experiments using anti-oxidant agents, togetherwith
the toxins could elucidate the suggested mechanism, as
showed for zearalenone (Ouanes et al., 2003).
The venoms from B. brazili and B. atrox did not induce
DNA damage when assayed by the comet test, however,
both showed genotoxic potential when assayed by the
micronucleus test. It is possible to conclude that the time of
incubationwith the cells, which was of 4 h, was not enough
to induce damage during the comet assay in contrast to the
48 h of incubation used in the micronucleus test.
Although various proteins from animal venoms have
been isolated and characterized enzymatically, pharmaco-
logically, toxicologically and/or structurally, the knowledge
concerning their biotechnological potential is still very
scarce, and each new research developed opens up new
possibilities of potential uses for the development of future
medications, which could bring fewer collateral effects
with major efﬁciency for the treatment of many degener-
ative diseases (Koh et al., 2006; Lomonte et al., 2010; King,
2011; Kang et al., 2011; Koh and Kini, 2012).
S. Marcussi et al. / Toxicon 65 (2013) 9–14145. Conclusion
The present work demonstrates the genotoxic potential
of B. jararacussu, B. brazili and B. atrox venoms, as well as
the isolated toxins BthTX-I, BthTX-II, BjussuMP-II and
BatxLAAO. Concentrations up to 5 mg/mL were able to
induce breakage in the DNA of human lymphocytes in the
tested conditions. The micronucleus test demonstrates the
perpetuation of DNA breakage in the ﬁrst cell generation
produced after the treatment, showing that the DNA breaks
were maintained even after the action of the cellular repair
systems. These results could also be related to other phar-
macological and toxic activities induced by venoms and
toxins, being useful for the elucidation of their mechanisms
of action.
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